British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have started final stage trials of a Covid-19 jab after positive early results, they announced Tuesday. The vaccine is facing a Phase 3 clinical trial to assess its “safety and immunogenicity” when compared with AstraZeneca’s Covid vaccine, the two companies said in a joint statement. […]
